Acute Complications of Preeclampsia

Total Page:16

File Type:pdf, Size:1020Kb

Acute Complications of Preeclampsia PROD. # GRF20214 CLINICAL OBSTETRICS AND GYNECOLOGY Volume 45, Number 2, 308–329 © 2002, Lippincott Williams & Wilkins, Inc. Acute Complications of Preeclampsia ERROL R. NORWITZ, MD, PhD,* CHAUR-DONG HSU, MD, MPH,† and JOHN T. REPKE, MD† Departments of Obstetrics & Gynecology, *Brigham & Women’s Hospital, Harvard Medical School, Boston, Massachusetts, and †University of Nebraska Medical Center, University of Nebraska Medical School, Omaha, Nebraska Preeclampsia is an idiopathic multisystem clinically as preeclampsia. Although attrac- disorder specific to human pregnancy and tive, this hypothesis remains to be validated. the puerperium.1 More precisely, it is a dis- Preeclampsia is a clinical diagnosis. The ease of the placenta, because it has also been classic definition of preeclampsia encom- described in pregnancies where there is tro- passes three elements: new-onset hyperten- phoblast but no fetal tissue (complete molar sion (defined as a sustained sitting blood pregnancies). Although the pathophysiol- pressure Ն140/90 mm Hg in a previously ogy of preeclampsia is poorly understood, it normotensive woman); new-onset protein- is clear that the blueprint for its development uria (defined as >300 mg/24 hours or Ն2+ is laid down early in pregnancy. It has been on a clean-catch urinalysis in the absence of suggested that the pathologic hallmark is a urinary tract infection); and new-onset sig- complete or partial failure of the second 1 nificant nondependent edema. However, wave of trophoblast invasion from 16 to 20 more recent consensus reports have sug- weeks’ gestation, which is responsible in gested eliminating edema as a criterion for normal pregnancies for destruction of the 3 muscularis layer of the spiral arterioles.2 As the diagnosis. pregnancy progresses, the metabolic de- A more extensive synopsis of preeclamp- mands of the fetoplacental unit increase. sia is beyond the scope of this discussion. However, because of the abnormally shal- This monograph serves to review in detail low invasion of the placenta, the spiral arte- the diagnosis and management of several rioles are unable to dilate to accommodate acute maternal complications of preeclamp- the required increase in blood flow, result- sia: eclampsia, HELLP (hemolysis, elevated ing in “placental dysfunction” that manifests liver enzymes, low platelets) syndrome, liver rupture, pulmonary edema, renal fail- ure, disseminated intravascular coagulopa- Correspondence: Errol R. Norwitz, MD, PhD, Depart- thy (DIC), hypertensive emergency, and hy- ment of Obstetrics & Gynecology, Brigham & Women’s Hospital, Harvard Medical School, 75 Francis Street, pertensive encephalopathy and cortical Boston, MA 02115. E-mail: [email protected] blindness. CLINICAL OBSTETRICS AND GYNECOLOGY / VOLUME 45 / NUMBER 2 / JUNE 2002 308 Acute Complications of Preeclampsia 309 Eclampsia ditions. Eclamptic seizures are almost al- Eclampsia refers to the occurrence of one or ways self-limiting and seldom last longer more generalized convulsions and/or coma than 3 to 4 minutes. Eclamptic seizures are in the setting of preeclampsia and in the ab- clinically and electroencephalographically sence of other neurologic conditions.1 In indistinguishable from other generalized the past, eclampsia was thought to be the tonic-clonic seizures. In general, women end result of preeclampsia, hence the no- with typical eclamptic seizures who do not menclature. However, it is now clear that have focal neurologic deficits or prolonged coma do not require either electroencepha- seizures are only one of several clinical 9 manifestation of “severe” preeclampsia. lographic or cerebral imaging studies. The precise cause of seizures in women Clinical conditions other than eclampsia that with eclampsia is not known. Proposed eti- should be considered when evaluating a ologies include cerebral vasospasm with pregnant woman who has had a seizure are local ischemia, hypertensive encephalopa- listed in Table 1. thy with hyperperfusion, vasogenic edema, Approximately half of all cases of 4 eclampsia occur before term, with more than and endothelial damage. Despite recent 7 advances in detection and management, 20% occurring before 31 weeks’ gestation. preeclampsia/eclampsia remains the second Three quarters of the remaining cases occur most common cause of maternal death in the at term, developing intrapartum or within 48 United States (after thromboembolic dis- hours of delivery. Seizures due to eclampsia ease), accounting for 15% of all maternal always resolve postpartum, often within a deaths.5 It is estimated that eclampsia ac- few hours to days. Diuresis (>4 L/day) is be- counts for 50,000 maternal deaths per year lieved to be the most accurate clinical indi- worldwide.6 cator of resolution of preeclampsia/eclampsia, but it is not a guarantee against the develop- ment of seizures.10 Indeed, late postpartum EPIDEMIOLOGY AND INCIDENCE eclampsia (eclamptic seizures developing Eclampsia is most common in nonwhite, >48 hours postpartum but <4 weeks postpar- nulliparous women from lower socioeco- nomic backgrounds. Peak incidence is in the TABLE 1. Differential Diagnosis of teenage years and early 20s, but there is also Eclampsia an increased prevalence in women older than 35. Eclampsia before 20 weeks’ gesta- Cerebrovascular accident tion is rare; this should raise the possibility Intracerebral hemorrhage of an underlying molar pregnancy or anti- Cerebral arterial or venous thrombosis Hypertensive diseases phospholipid antibody syndrome. Hypertensive encephalopathy The overall incidence of eclampsia is Pheochromocytoma relatively stable, at 4 to 5 cases per 10,000 Space-occupying lesions of the central nervous live births in developed countries.7 In devel- system oping countries, however, the incidence var- Brain tumor Abscess ies widely from 6 to 100 per 10,000 live Metabolic disorders 8 births. Hypoglycemia Uremia Inappropriate antidiuretic hormone secretion CLINICAL MANIFESTATIONS AND resulting in water intoxication DIAGNOSIS Infectious etiology Eclampsia is a clinical diagnosis based on Meningitis evidence of one or more generalized convul- Encephalitis sions and/or coma in a preeclamptic woman Thrombotic thrombocytopenic purpura Idiopathic epilepsy and in the absence of other neurologic con- 310 NORWITZ ET AL tum) accounts for 25% of postpartum cases system, where it achieves anticonvulsant and up to 16% of all cases of eclampsia.10,11 levels within 1 minute, and it will control seizures in greater than 80% of patients MANAGEMENT within 5 minutes.13 However, most investi- A number of management strategies have gators recommend avoiding benzodiaz- been developed to prevent maternal and fe- epines because of the potentially profound tal complications resulting from eclampsia depressant effects on the fetus. This effect during the peripartum period. The immedi- becomes clinically significant when the total ate issues in caring for an eclamptic woman maternal dose of diazepam exceeds 30 mg. include maintenance of maternal vital func- tions, control of convulsions and blood pres- Treatment of Hypertension sure, prevention of recurrent seizures, and Cerebrovascular accident accounts for 15– evaluation for delivery. If the seizure is wit- 20% of deaths from eclampsia. The risk of nessed, maintenance of airway patency and hemorrhagic stroke correlates directly with prevention of aspiration should be the first the degree of elevation in systolic blood responsibilities of management. The partu- pressure and is less related to, but not inde- rient should be rolled onto her left side and a pendent of, the diastolic pressure.14 It is not padded tongue blade placed in her mouth, if clear whether there is a threshold pressure possible. above which emergent therapy should be in- stituted.14 Most investigators recommend Control of Convulsions aggressive antihypertensive therapy for sus- Although eclamptic seizures usually resolve tained diastolic pressures of more than 105 without treatment within 3 to 4 minutes, an to 110 mm Hg and systolic blood pressures anticonvulsant can be administered to of 160 mmHg or greater,3 although these achieve resolution of an ongoing convul- thresholds have not been tested prospec- sion. The treatment of choice is magnesium tively. The cerebral vasculature of women sulfate. In women already receiving magne- with underlying chronic hypertension can sium seizure prophylaxis, a serum magne- probably tolerate higher systolic pressures sium level should be obtained immediately without injury, whereas adolescents with and a rapid intravenous infusion of 1 to 2 g normally low blood pressures may benefit administered while awaiting the results. In from starting treatment at lower levels. Per- women not receiving seizure prophylaxis, sistent, severe elevation in blood pressure magnesium should be given as a rapid intra- (Ն160/110 mm Hg) should be treated to pre- venous infusion of 2 g repeated every 15 vent cerebrovascular accident. Initial treat- minutes to a maximum of 6 g. This loading ment options include hydralazine (5 mg in- dose may be given safely even in the pres- travenous push followed by 5- to 10-mg bo- ence of renal insufficiency. Exactly how luses as needed q 20 minutes) or labetalol magnesium acts as an anticonvulsant in (10–20 mg intravenous push, repeat q 10–20 eclampsia is not known. Several mecha- minutes with doubling doses not to exceed nisms have been proposed, including selec- 80 mg in any single dose, for a maximum tive vasodilatation of the cerebral vascula- total cumulative dose
Recommended publications
  • Complication Prevention for Patients with Diabetes a Noncommunicable Disease Education Manual for Primary Health Care Professionals and Patients
    Complication prevention for patients with diabetes A noncommunicable disease education manual for primary health care professionals and patients Complication prevention for patients with diabetes A noncommunicable disease education manual for primary health care professionals and patients The Noncommunicable Disease Education Manual for Primary Health Care Professionals and Patients results from the contributions and hard work of many people. Its development was led by Dr Hai-Rim Shin, Coordinator, and Dr Warrick Junsuk Kim, Medical Officer, of the Noncommunicable Diseases and Health Promotion unit at the WHO Regional Office for the Western Pacific (WHO/WPRO/NCD) in Manila, Philippines. WHO graciously acknowledges the intellectual contributions of Dr Jung-jin Cho, Co-director, Community-based Primary Care Project Committee and Professor, Department of Family Medicine, Hallym University Sacred Heart Dongtan Hospital, Republic of Korea; Dr Hyejin Lee, Volunteer, WHO/WPRO/NCD (currently PhD candidate, Department of Family Medicine, Seoul National University, Republic of Korea); Ms Saki Narita, Volunteer, WHO/WPRO/NCD (currently PhD candidate, Department of Global Health Policy, Graduate School of Medicine, University of Tokyo, Japan); and Mr Byung Ki Kwon, Technical Officer, WHO/WPRO/NCD (currently Director, Division of Health Promotion, Ministry of Health and Welfare, Republic of Korea). Many thanks to Dr Albert Domingo, Dr Sonia McCarthy, Ms Marie Clem Carlos, Dr Katrin Engelhardt, Mr Kelvin Khow Chuan Heng and Dr Roberto Andres Ruiz from the WHO Regional Office for the Western Pacific and Dr Ma. Charina Benedicto, Physician-in-Charge, Bagong Barangay Health Center & Lying-in Clinic, Pandacan, Manila, Philippines for reviewing the draft publication. Financial support for this publication was received from the Korea Centers for Disease Control and Prevention, Republic of Korea.
    [Show full text]
  • Risk Factors and Complications in Type 2 Diabetes Outpatients
    RISKORIGINAL FACTORS AND COMPLICATIONS ARTICLE IN TYPE 2 DIABETES OUTPATIENTS Risk factors and complications in type 2 diabetes outpatients ELLEN FERNANDES FLávIO SILVA1, CRISTIANE MARIA MENDES FERREIRA2*, LUCINEIA DE PINHO3 1Medical Student, Faculdades Unidas do Norte de Minas (Funorte), Montes Claros, MG, Brazil 2Endocrinologist, Universidade Estadual de Montes Claros (Unimontes), Montes Claros, MG, Brazil 3PhD in Health Sciences, Unimontes and Funorte, Montes Claros, MG, Brazil SUMMARY Objective: Our study investigated type 2 diabetes mellitus (T2DM) outpatients attending a university hospital in Montes Claros, MG, to estimate the prevalence of risk factors and their association with diabetes complications. Method: This was a quantitative, documental, retrospective and analytical study. Medical records of 95 outpatients with T2DM treated in this hospital from 2011 to 2015 were analyzed. Data were collected according to a structured questionnaire surveying sociodemographic, anthropometric and biochemical data and clinical and lifestyle aspects. Regression analysis was used to evaluate the association between risk factor variables and complications. Results: With a mean age of 54 years, the study population showed irregular blood glucose control, despite the use of hypoglycemic medication, and did not Study conducted at Universidade have a healthy lifestyle. The main complication reported was high blood pressure Estadual de Montes Claros (Unimontes), Montes Claros, MG, Brazil (HBP), occurring in 70.9% of patients. The prevalence of complications was positively associated with patients receiving insulin treatment (p=0.042) and Article received: 11/13/2016 Accepted for publication: 12/19/2016 multidisciplinary monitoring (p=0.050). Conclusion: The associations identified reflect the condition of patients that *Correspondence: Address: Av. Dr.
    [Show full text]
  • Incidence of Eclampsia with HELLP Syndrome and Associated Mortality in Latin America
    International Journal of Gynecology and Obstetrics 129 (2015) 219–222 Contents lists available at ScienceDirect International Journal of Gynecology and Obstetrics journal homepage: www.elsevier.com/locate/ijgo CLINICAL ARTICLE Incidence of eclampsia with HELLP syndrome and associated mortality in Latin America Paulino Vigil-De Gracia a,⁎, José Rojas-Suarez b, Edwin Ramos c, Osvaldo Reyes d, Jorge Collantes e, Arelys Quintero f,ErasmoHuertasg, Andrés Calle h, Eduardo Turcios i,VicenteY.Chonj a Critical Care Unit, Department of Obstetrics and Gynecology, Complejo Hospitalario de la Caja de Seguro Social, Panama City, Panama b Critical Care Unit, Clínica de Maternidad Rafael Calvo, Cartagena, Colombia c Department of Gynecology and Obstetrics, Hospital Universitario Dr Luis Razetti, Barcelona, Venezuela d Unit of Research, Department of Gynecology and Obstetrics, Hospital Santo Tomás, Panama City, Panama e Department of Gynecology and Obstetrics, Hospital Regional de Cojamarca, Cajamarca, Peru f Department of Gynecology and Obstetrics, Hospital José Domingo de Obaldía, David, Panama g Unit of Perinatology, Department of Gynecology and Obstetrics, Instituto Nacional Materno Perinatal, Lima, Peru h Department of Gynecology and Obstetrics, Hospital Carlos Andrade Marín, Quito, Ecuador i Unit of Research, Department of Gynecology and Obstetrics, Hospital Primero de Mayo de Seguridad Social, San Salvador, El Salvador j Department of Gynecology and Obstetrics, Hospital Teodoro Maldonado Carbo, Guayaquil, Ecuador article info abstract Article history: Objective: To describe the maternal outcome among women with eclampsia with and without HELLP syndrome Received 7 July 2014 (hemolysis, elevated liver enzymes, and low platelet count). Methods: A cross-sectional study of women with Received in revised form 14 November 2014 eclampsia was undertaken in 14 maternity units in Latin America between January 1 and December 31, 2012.
    [Show full text]
  • Vitamin D, Pre-Eclampsia, and Preterm Birth Among Pregnancies at High Risk for Pre-Eclampsia: an Analysis of Data from a Low-Dos
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author BJOG. Author Manuscript Author manuscript; Manuscript Author available in PMC 2021 January 29. Published in final edited form as: BJOG. 2017 November ; 124(12): 1874–1882. doi:10.1111/1471-0528.14372. Vitamin D, pre-eclampsia, and preterm birth among pregnancies at high risk for pre-eclampsia: an analysis of data from a low- dose aspirin trial AD Gernanda, HN Simhanb, KM Bacac, S Caritisd, LM Bodnare aDepartment of Nutritional Sciences, The Pennsylvania State University, University Park, PA, USA bDivision of Maternal-Fetal Medicine, Magee-Women’s Hospital and Department of Obstetrics, Gynecology and Reproductive Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA cDepartment of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA dDepartment of Obstetrics, Gynecology and Reproductive Sciences and Department of Pediatrics, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA eDepartments of Epidemiology and Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh Graduate School of Public Health and School of Medicine, Pittsburgh, PA, USA Abstract Objective—To examine the relation between maternal vitamin D status and risk of pre-eclampsia and preterm birth in women at high risk for pre-eclampsia. Design—Analysis of prospectively collected data and blood samples from a trial of prenatal low- dose aspirin. Setting—Thirteen sites across the USA. Population—Women at high risk for pre-eclampsia. Methods—We measured 25-hydroxyvitamin D [25(OH)D] concentrations in stored maternal serum samples drawn at 12–26 weeks’ gestation (n = 822). We used mixed effects models to Correspondence: LM Bodnar, University of Pittsburgh Graduate School of Public Health, A742 Crabtree Hall, 130 DeSoto St, Pittsburgh, PA 15261, USA.
    [Show full text]
  • Policy of Interventionist Versus Expectant Management of Severe
    WHO recommendations Policy of interventionist versus expectant management of severe pre-eclampsia before term WHO recommendations Policy of interventionist versus expectant management of severe pre-eclampsia before term WHO recommendations: policy of interventionist versus expectant management of severe pre-eclampsia before term ISBN 978-92-4-155044-4 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. WHO recommendations: policy of interventionist versus expectant management of severe pre-eclampsia before term. Geneva: World Health Organization; 2018.
    [Show full text]
  • Ophthalmic Associations in Pregnancy
    CLINICAL Ophthalmic associations in pregnancy Queena Qin, Celia Chen, Sudha Cugati PREGNANCY RESULTS in various physiological variation in pregnancy.2 It normally changes in the female body, including in fades slowly after pregnancy and does the eyes. A typical pregnancy results in not need active intervention. Background A range of ocular pathology exists cardiovascular, pulmonary, metabolic, • Cornea – corneal thickness, curvature during pregnancy. Some pre-existing eye hormonal and immunological changes. and sensitivity may be altered during conditions, such as diabetic retinopathy, Hormonal changes occur, with a rise of pregnancy. Corneal thickness and can be exacerbated during pregnancy. oestrogen and progesterone levels to curvature can increase in pregnancy, Other conditions manifest for the first suppress the menstrual cycle.1 especially in the second and third time during pregnancy as a result of The eye, an end organ, undergoes trimesters, and return to normal in complications such as pre-eclampsia changes during pregnancy. Some of the postpartum period.3 Patients who and eclampsia. Early recognition and understanding of the management of these changes exacerbate pre-existing wear contact lenses may experience ophthalmic conditions is crucial. eye conditions, while other conditions intolerance to the use of contact lenses. manifest for the first time during Pregnant women should be advised Objective pregnancy. Early recognition and to delay obtaining a new prescription The aim of this article is to discuss the understanding of management of for glasses or undergoing a contact physiological and pathological changes in the eyes of pregnant women. ophthalmic conditions during pregnancy lens fitting until after delivery. Laser Pathological changes are sub-divided is crucial for the primary care physician.
    [Show full text]
  • Your Guide to Living Well with Heart Disease
    YOUR GUIDE TO Living Well Wi t h H e a rt Disease U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute NIH Publication No. 06–5270 November 2005 Written by: Marian Sandmaier U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute C o n t e n t s Introduction . 1 Heart Disease: A Wakeup Call . 2 What Is Heart Disease? . 4 Getting Tested for Heart Disease . 7 Controlling Your Risk Factors . 10 You and Your Doctor: A Healthy Partnership . 12 Major Risk Factors . 13 Smoking . 13 High Blood Pressure . 14 High Blood Cholesterol . 18 Overweight and Obesity . 23 Physical Inactivity. 26 Diabetes . 27 What Else Affects Heart Disease? . 31 Stress . 31 Alcohol . 31 Sleep Apnea. 32 Menopausal Hormone Therapy . 33 C-Reactive Protein . 33 Treatments for Heart Disease . 34 Medications . 34 Managing Angina . 38 Procedures. 41 Coronary Angioplasty, or “Balloon” Angioplasty. 42 Plaque Removal . 42 Stent Placement . 42 Coronary Bypass Surgery . 44 Getting Help for a Heart Attack. 46 Know the Warning Signs. 46 Get Help Quickly . 46 Plan Ahead. 49 Recovering Well: Life After a Heart Attack or Heart Procedure. 51 Your First Weeks at Home. 52 Cardiac Rehabilitation . 55 Getting Started . 55 How To Choose a Cardiac Rehab Program . 56 What You’ll Do in a Cardiac Rehab Program. 56 Getting the Most Out of Cardiac Rehab . 57 Getting Your Life Back . 59 Coping With Your Feelings . 60 Caring for Your Heart . 63 To Learn More . 64 1 I n t r o d u c t i o n Chances are, you’re reading this book because you or someone close to you has heart disease.
    [Show full text]
  • Pre-Eclampsia and High Blood Pressure During Pregnancy
    Pre-eclampsia and High Blood Pressure During Pregnancy What is high blood pressure? A blood pressure measurement is usually recorded as two numbers, Blood pressure is the force that pushes against your blood vessel such as 120 over 80 (120/80). High blood pressure is also called walls each time your heart squeezes and relaxes to pump the blood hypertension. Hypertension is diagnosed when either the top or the through your body. Blood pressure measurement is a very useful bottom number is higher than normal. way to monitor the health of your cardiovascular system (heart and blood vessels). Why is blood pressure important develops, it does not go away until after the baby is born. Women with pre-eclampsia may require an earlier delivery, during pregnancy? either by labour induction or caesarean section, in order to During pregnancy, very high blood pressure (severe hypertension) protect the health of themselves and their baby. In some cases, can cause complications for both you and your baby, including: pre-eclampsia can develop after childbirth and you should • Poor growth of your baby – due to low nutrition and oxygen alert your doctor or midwife of any concerns you may have supply from the placenta after your baby is born. • Prematurity – if early delivery (before 37 weeks) is required to protect the health of you or your baby • Placental abruption – the placenta may prematurely separate from the wall of the uterus (womb), leading to bleeding and the need for an emergency birth in some cases • Pre-eclampsia – a condition involving high blood pressure and abnormal function in one or more organs during pregnancy What are the different types of high blood pressure that affect pregnant women? 1.
    [Show full text]
  • What Is Dvt? Deep Vein Thrombosis (DVT) Occurs When an Abnormal Blood Clot Forms in a Large Vein
    What is DVt? Deep vein thrombosis (DVT) occurs when an abnormal blood clot forms in a large vein. These clots usually develop in the lower leg, thigh, or pelvis, but can also occur in other large veins in the body. If you develop DVT and it is diagnosed correctly and quickly, it can be treated. However, many people do not know if they are at risk, don’t know the symptoms, and delay seeing a healthcare professional if they do have symptoms. CAn DVt hAppen to me? Anyone may be at risk for DVT but the more risk factors you have, the greater your chances are of developing DVT. Knowing your risk factors can help you prevent DVt: n Hospitalization for a medical illness n Recent major surgery or injury n Personal history of a clotting disorder or previous DVT n Increasing age this is serious n Cancer and cancer treatments n Pregnancy and the first 6 weeks after delivery n Hormone replacement therapy or birth control products n Family history of DVT n Extended bed rest n Obesity n Smoking n Prolonged sitting when traveling (longer than 6 to 8 hours) DVt symptoms AnD signs: the following are the most common and usually occur in the affected limb: n Recent swelling of the limb n Unexplained pain or tenderness n Skin that may be warm to the touch n Redness of the skin Since the symptoms of DVT can be similar to other conditions, like a pulled muscle, this often leads to a delay in diagnosis. Some people with DVT may have no symptoms at all.
    [Show full text]
  • 37267-A-Rare-Complication-Of-Myocardial-Infarction-Ventricular-Septal-Defect.Pdf
    Open Access Case Report DOI: 10.7759/cureus.9725 A Rare Complication of Myocardial Infarction: Ventricular Septal Defect Sherif Elkattawy 1 , Ramez Alyacoub 1 , Muhammad Atif Masood Noori 1 , Afrah Talpur 1 , Karim Khimani 2 1. Internal Medicine, Rutgers New Jersey Medical School/Trinitas Regional Medical Center, Elizabeth, USA 2. Internal Medicine, Rutger New Jersey Medical School/Trinitas Regional Medical Center, Elizabeth, USA Corresponding author: Karim Khimani, [email protected] Abstract Ventricular septal defect (VSD) is a rare but lethal complication of myocardial infarction. We present a case of a 65-year-old male who presented with a history of progressive shortness of breath associated with productive cough. Physical examination was significant for crepitation in both lower lung fields and bilateral lower extremity edema. Chest X-ray revealed bilateral reticular opacities with small bilateral pleural effusions. Polymerase chain reaction (PCR) for COVID was positive. Echo showed a left ventricular ejection fraction (LVEF) of 30-35%, ischemic cardiomyopathy, and muscular ventricular septal defects with left to right shunting and severely elevated pulmonary artery systolic pressure. Overtime during the hospital course, he developed respiratory and fulminant hepatic failure. Our patient had VSD due to an undiagnosed old myocardial infarction (MI). Initially heart failure was compensated and treated with medical management. Later on, he developed respiratory complications related to COVID-19 infection as well as hepatic failure in addition to a cardiomyopathy which made him a poor surgical candidate leading to death. Categories: Cardiac/Thoracic/Vascular Surgery, Cardiology, Internal Medicine Keywords: ventricular septal defect (vsd), complication of mi, interventricular septum Introduction A ventricular septal defect (VSD) is an abnormal communication between the left and right ventricle through a defect in the septal wall of the heart.
    [Show full text]
  • HPN Complication Chart
    HPN Complication Chart Users are strongly advised to review this chart with their MD, noting any differences in protocols/procedures, prior to taking 214 Hun Memorial, MC 28 any actions recommended by this chart. The chart is intended as a helpful reference, and should not replace the advice of Albany Medical Center your MD. Users should read the entire chart, at least briefly, comparing symptoms listed in each section with those actually experienced by the consumer, before taking any action. Albany, NY 12208 (800) 776-OLEY/(518) 262-5079 Fax: (518) 262-5528 www.oley.org [email protected] METABOLIC (Catheter/Pump Complications on Back) Infection Symptoms: Temperature one degree or more above baseline/normal temperature; chills, especially occurring with infusion; sweating; lethargy; body aches; urine spot checks may show glucose levels greater than 1/2%. A. systemic Cause: Poor aseptic technique during connection/disconnection procedures; contaminated tubing or heparin or saline flushes; infection: contaminated IV solution; exposure to illness outside body (flu, cold, chicken pox, etc.) or inside body (urinary tract infection, dental abscess/caries, fistulae, ileostomy/colostomy/gastrostomy sites, etc.); routine dental work without prophylactic antibiotic coverage. Immediate Action: Call MD immediately. If MD unavailable, go to local emergency room. Prevention: Use proper aseptic technique at all times, including meticulous handwashing. Inspect all solutions beforehand for clouding/particulate matter. If possible, avoid individuals with known illnesses or possible exposure to communicable diseases. Schedule routine dental checkups; inform dentist of indwelling central venous access (catheter) and follow protocol for prophylactic antibiotic coverage for dental work as prescribed by primary MD (call Oley for suggested protocol if needed).
    [Show full text]
  • Shoulder Dystocia Abnormal Placentation Umbilical Cord
    Obstetric Emergencies Shoulder Dystocia Abnormal Placentation Umbilical Cord Prolapse Uterine Rupture TOLAC Diabetic Ketoacidosis Valerie Huwe, RNC-OB, MS, CNS & Meghan Duck RNC-OB, MS, CNS UCSF Benioff Children’s Hospital Outreach Services, Mission Bay Objectives .Highlight abnormal conditions that contribute to the severity of obstetric emergencies .Describe how nurses can implement recommended protocols, procedures, and guidelines during an OB emergency aimed to reduce patient harm .Identify safe-guards within hospital systems aimed to provide safe obstetric care .Identify triggers during childbirth that increase a women’s risk for Post Traumatic Stress Disorder and Postpartum Depression . Incorporate a multidisciplinary plan of care to optimize care for women with postpartum emergencies Obstetric Emergencies • Shoulder Dystocia • Abnormal Placentation • Umbilical Cord Prolapse • Uterine Rupture • TOLAC • Diabetic Ketoacidosis Risk-benefit analysis Balancing 2 Principles 1. Maternal ‒ Benefit should outweigh risk 2. Fetal ‒ Optimal outcome Case Presentation . 36 yo Hispanic woman G4 P3 to L&D for IOL .IVF Pregnancy .3 Prior vaginal births: 7.12, 8.1, 8.5 (NCB) .Late to care – EDC ~ 40-41 weeks .GDM Type A2 – somewhat uncontrolled .4’11’’ .Hx of Lupus .BMI 40 .Gained ~ 40 lbs during pregnancy Question: What complication is she a risk for? a) Placental abruption b) Thyroid Storm c) Preeclampsia with severe features d) Shoulder dystocia e) Uterine prolapse Case Presentation . 36 yo Hispanic woman G4 P3 to L&D for IOL .IVF Pregnancy .3
    [Show full text]